For many people with Crohn’s disease or ulcerative colitis, colonoscopy becomes routine. But it only shows part of the picture, especially when disease sits higher up in the small bowel, beyond a standard camera’s reach. This is where MRI, CT and capsule endoscopy come in, offering different ways to see areas other tests cannot.
What these tests are
MRI uses magnetic fields and radio waves to build detailed images of soft tissue, including the bowel wall, without radiation. CT combines a series of X-ray images taken from different angles into cross-sectional pictures of the abdomen. Capsule endoscopy involves swallowing a small camera that takes thousands of images as it travels through the digestive tract, transmitting them to a recorder worn on a belt. Together, these tools help map the extent, location and severity of inflammatory bowel disease (IBD) in ways a camera passed from below cannot always achieve.
Why it matters for gut inflammation
Crohn’s disease can affect any part of the digestive tract, from mouth to anus, with inflammation sometimes sitting deep in the bowel wall or in the small intestine, beyond a colonoscope’s reach. Ulcerative colitis is generally confined to the colon, but complications and activity outside the visible lining still need assessing. Imaging can reveal wall thickening, strictures (narrowed bowel sections), fistulas (abnormal tunnels connecting bowel to other organs or skin), and abscesses (infection pockets), none of which endoscopy alone always detects. This detail shapes decisions about medication, monitoring and, when needed, surgery.
Key mechanisms and clinical context
Magnetic resonance enterography
This MRI variant focuses on the small bowel, often after drinking a contrast liquid that distinguishes bowel loops from surrounding tissue. It is especially useful in Crohn’s disease, detecting active inflammation, measuring bowel wall thickness, and identifying strictures or fistulas without radiation. This makes it well suited to repeated use, particularly for younger patients or those needing frequent monitoring.
CT scanning
CT produces detailed cross-sectional images quickly, making it valuable in urgent situations such as suspected obstruction, perforation, or abscess. It is often the first-choice emergency test due to its speed and availability. The trade-off is ionising radiation exposure, so CT is generally reserved for situations prioritising speed and clarity rather than routine monitoring.
Capsule endoscopy
Capsule endoscopy allows direct visualisation of the small bowel lining, an area traditional endoscopy struggles to reach. It is useful when Crohn’s is suspected but unconfirmed, or when monitoring known small bowel disease. Beforehand, a dissolvable patency capsule checks the bowel is not too narrow, reducing the risk of the real capsule becoming stuck at a stricture.
Choosing between tests
The choice depends on the clinical question. Repeated, radiation-free monitoring of small bowel Crohn’s favours MRI. A rapid answer in an acute setting often means CT despite its radiation exposure. Concern about subtle mucosal disease not visible on cross-sectional imaging may prompt capsule endoscopy. Gastroenterologists often combine these tools with blood tests, faecal calprotectin (a stool inflammation marker) and colonoscopy for a fuller picture.
Complementing, not replacing, endoscopy
These tools work alongside colonoscopy, not in place of it. Colonoscopy allows direct visual inspection and biopsy sampling of the colon and lower small bowel, which imaging cannot provide. Combining imaging and endoscopy gives a fuller map of where inflammation is active, its severity, and whether complications like strictures have developed.
These tests assess structural and inflammatory changes, not symptoms directly. Some people with visible inflammation feel relatively well, while others with significant symptoms show minimal changes on imaging. Symptoms don’t always correlate with disease activity, which is why clinicians rely on combined testing rather than symptoms alone. None of this should be used to self-diagnose or adjust treatment without medical guidance.
Practical takeaways
- Ask your gastroenterology team which imaging test suits your disease location and history, as this varies between patients.
- If offered capsule endoscopy, expect a patency capsule test first if you have any history of strictures.
- Track when and where you’ve had MRI, CT or capsule endoscopy; this history helps guide future monitoring and reduces unnecessary repeat radiation.
- Don’t assume symptoms alone indicate a flare or remission; imaging and other objective markers often tell a fuller story.
- Discuss any concerns about CT radiation exposure with your care team, as MRI alternatives may be available depending on the clinical question.
Conclusion
MRI, CT and capsule endoscopy each offer a distinct way of seeing inside the digestive tract, filling gaps colonoscopy alone cannot cover. Combined with blood and stool markers, they build a fuller, more accurate picture of where inflammation sits and how it behaves over time. No single test tells the whole story, which is why a combined approach remains central to long-term IBD management. Always discuss the purpose and timing of any imaging test with your specialist team.
References
- Panes J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther. 2011;34(2):125-145. doi:10.1111/j.1365-2036.2011.04710.x
- Rimola J, Rodriguez S, Garcia-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58(8):1113-1120. doi:10.1136/gut.2008.167957
- Kopylov U, Yablecovitch D, Lahat A, et al. Detection of small bowel mucosal healing and deep remission in patients with known small bowel Crohn’s disease using biomarkers, capsule endoscopy, and imaging. Am J Gastroenterol. 2015;110(9):1316-1323. doi:10.1038/ajg.2015.221
- Leighton JA, Legnani P, Seidman EG. Role of capsule endoscopy in inflammatory bowel disease: where we are and where we are going. Inflamm Bowel Dis. 2007;13(3):331-337. doi:10.1002/ibd.20017
- Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247(1):64-79. doi:10.1148/radiol.2471070611
- Cheifetz AS, Kornbluth AA, Legnani P, et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn’s disease. Am J Gastroenterol. 2006;101(10):2218-2222. doi:10.1111/j.1572-0241.2006.00761.x
- Bettenworth D, Bokemeyer A, Baker M, et al. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut. 2019;68(6):1115-1126. doi:10.1136/gutjnl-2018-318081
This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.